Zibb.com: Boston Scientific Corporation (Industry News & Blogs)

Thermal Scalpel enters into license agreement with Boston Scienti...

Wed, 25 Nov 2009 13:48:35 GMT

Thermal Scalpel, LLC has entered into a licensing agreement with Boston Scientific Corporation, a developer, manufacturer and marketer of medical devices. Both the companies are based in the US. Thermal Scalpel is a subsidiary of Acacia Research Corporation, which through its operating

Boston Scientific to Participate in Piper Jaffray Health Care Con...

Mon, 23 Nov 2009 22:01:00 GMT

NATICK, Mass., Nov. 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, December 1-2.

Boston Scientific to leave Doral

Sat, 21 Nov 2009 13:49:45 GMT

He added that some Boston Scientific employees contacted the city about possibly pulling a permit to protest, but he wasnâ€™t clear whether that ever happened. A call to Boston Scientific seeking comment was not returned.

Boston Scientific gets marketing OK for esophageal stent

Fri, 20 Nov 2009 18:26:57 GMT

The Natick-based company (NYSE: BSX) received U.S. Food and Drug Administration and European CE Mark approvals to market the stent for the treatment of malignant esophageal obstructions caused by tumors in patients with esophageal cancer.

Boston Scientific initiated with "neutral"

Thu, 12 Nov 2009 18:12:21 GMT

NEW YORK, November 12 (newratings.com) - Analysts at Wedbush Morgan initiate coverage of Boston Scientific (ticker: BSX) with a "neutral" rating. The target price is set to $8. [more]

This Company Is a Value Stock! Isn't It?

Wed, 11 Nov 2009 21:06:30 GMT

The Motley Fool - A look at Boston Scientific leads to conflicting conclusions.

Boston Scientific sponsors World Diabetes Day 2009

Tue, 10 Nov 2009 11:50:00 GMT

A worldwide developer, manufacturer and marketer of medical devices announced its official sponsorship of World Diabetes Day for the second year in a row. The program is organized by the International Diabetes Federation and represents its primary global awareness campaign in the fight against

News and FDA Updates for Ferro (NYSE:FOE), Boston Scientific (NYS...

Sat, 07 Nov 2009 08:24:18 GMT

We are an online magazine for national, international, state, local, entertainment, sports, and government news. We also provide opinion and feature articles.

Boston Scientific Settles with Justice Department

Fri, 06 Nov 2009 19:17:23 GMT

Boston Scientific (BSX), the medical device maker, announced a payment of $296 million to settle an investigation by the Department of Justice into the company’s Guidant division.

Boston Scientific to Settle DOJ Defibrillator Case - Wall Street ...

Fri, 06 Nov 2009 19:04:18 GMT

Dow Jones Reprints: This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool at the bottom of any article or visit www.djreprints.com See a sample reprint in PDF format.

Boston Scientific Sets $296 Million Settlement on Devices (at The...

Fri, 06 Nov 2009 18:30:02 GMT

The company's Guidant unit will plead guilty to two misdemeanor charges related to improper reporting to the FDA

Boston Scientific paying $296 million to settle DOJ investigation...

Fri, 06 Nov 2009 18:26:00 GMT

NEW YORK - Medical device maker Boston Scientific Corp. said Friday it will pay $296 million to sett

Boston Scientific paying $296 million settlement

Fri, 06 Nov 2009 17:41:00 GMT

NEW YORK (AP) — Medical device maker Boston Scientific says it will pay $296 million to settle a Department of Justice investigation into the company's Guidant unit.

Boston Scientific to Pay $296 Million in Settlement

Fri, 06 Nov 2009 17:40:07 GMT

Incisive Media's Law.com is the Web's leading legal news and information network for attorneys and other legal professionals.

UPDATE 3-Boston Scientfic to pay $296 mln to settle US probe - Re...

Fri, 06 Nov 2009 17:02:50 GMT

* Reaches agreement with U.S. DOJ over Guidant advisories * To pay $296 million as part of deal * Will record Q3 charge of $294 million * Sees 2009 EPS of 75-79 cents, excluding items * Shares

Boston Scientific Pays $296 Million to Settle Probe - Bloomberg

Fri, 06 Nov 2009 16:12:23 GMT

[bn:WBTKR=BSX:US] Boston Scientific Corp. [] agreed to pay $296 million to settle a U.S. Justice Department investigation into its Guidant unit’s handling of heart devices and restated third-quarter results to show a loss.

Boston Scientific To Pay $296 Million Settlement

Fri, 06 Nov 2009 15:21:00 GMT

Medical device maker Boston Scientific says it will pay $296 million to settle a Department of Justice investigation into the company's Guidant unit.

Boston Scientific Reaches $296 Million Settlement In Guidant Case...

Fri, 06 Nov 2009 14:39:56 GMT

Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. * : Time reflects local markets trading time.

Boston Scientific paying $296 million settlement

Fri, 06 Nov 2009 14:03:38 GMT

Medical device maker Boston Scientific says it will pay $296 million to settle a Department of Justice investigation into the company's Guidant unit. The investigation involved product advisories issued by Guidant in 2005, a year before Boston Scientific paid...

Boston Sci settles Guidant probe with DOJ

Fri, 06 Nov 2009 13:50:41 GMT

BOSTON (MarketWatch) -- Boston Scientific Corp. said Friday that it has agreed in principle to settle an investigation with the Department of Justice for $296 million. The probe focused on the former Guidant Corp.'s 2005 warnings on its Contak Renewal and Ventak Prizm medical device products.

Boston Scientific stent wins European approval (at bizjournals.co...

Mon, 02 Nov 2009 19:05:33 GMT

Boston Scientific Corp. on Monday said European regulators have approved its Promus Element stent — the latest version of the company’s drug-coated stent technology meant to prop open previously clogged arteries.

New Boston Scientific Stent Approved in Europe

Mon, 02 Nov 2009 16:46:22 GMT

Medical device maker Boston Scientific said Monday it received European marketing approval for its latest drug-coated stent technology, which prevents blocked arteries. The company said it will begin marketing its Promus Element stent in the European Union immediately.

New Boston Scientific stent approved in Europe (AP)

Mon, 02 Nov 2009 16:46:16 GMT

NATICK, Mass. (AP) -- Medical device maker Boston Scientific said Monday it received European marketing approval for its latest drug-coated stent technology, which prevents blocked arteries.The

New Boston Scientific stent approved in Europe

Mon, 02 Nov 2009 15:55:52 GMT

Medical device maker Boston Scientific said Monday it received European marketing approval for its latest drug-coated stent technology, which prevents blocked arteries.

Video: Boston Scientific Announces European Approval and Launch o...

Mon, 02 Nov 2009 13:45:31 GMT

NATICK, Mass., Nov. 2 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS Element(TM) Everolimus-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent (DES) technology. The PROMUS Element system